William Hagopian launched The Environmental Determinants of Diabetes in the Young study
In 2004, William Hagopian, M.D., Ph.D., launched The Environmental Determinants of Diabetes in the Young (TEDDY) study at…
In 2004, William Hagopian, M.D., Ph.D., launched The Environmental Determinants of Diabetes in the Young (TEDDY) study at…
In 2004, the Emergency Use Authorization (EUA) program was established in 2004, when the Project BioShield Act, among…
In 2004, Wisconsin Governor Jim Doyle proposed the Wisconsin Institutes for Discovery (WID), a UW-Madison research enterprise, to…
In 2004, the National Cancer Institute (NCI) collaborated with the Department of Health and Human Services to establish…
In 2004, data from the Women’s Health Initiative (WHI) study show that women who take estrogen in combination…
On Nov. 21, 2003, Cialis (tadalafil), discovered through a Glaxo Wellcome and ICOS Corp. partnership, was first approved…
On Nov. 19, 2003, a novel approach to treatment of solid cancers involved therapeutic agents that inhibit the…
On Nov. 12, 2003, Iowa State University announced new soybean varieties, that don’t need to be hydrogenated, that…
On Oct. 21, 2003, scientists at Oregon Health Sciences University’s (OHSU) Casey Eye Institute announced they had found…
On Oct. 16, 2003, scientists from the Oklahoma Medical Research Foundation (OMRF) and the University of Oklahoma Health…
On Oct. 15, 2003, the Immunization Practices Advisory Committee (ACIP) voted to recommend that children 6 to 23…
On Oct. 9, 2003, a Canadian-led international clinical trial found that post-menopausal survivors of early-stage breast cancer who…
On Oct. 9, 2003, The Scripps Research Institute (TSRI) announced the establishment of a major science center in…
On Sept. 29, 2003, $81 million was awarded by National Institute of Allergy and Infectious Diseases (NIAID) through…
On Sept. 16, 2003, The Allen Institute for Brain Science, a division of the Allen Institute, was established…
On Sept. 4, 2003, the National Center for Research Resources (NCCR) awarded a $6.7 million grant to the…
On Sept. 3, 2003, the death rates from the four most common cancers, – lung, breast, prostate, and…
On Aug. 17, 2003, Oregon Health & Science University (OHSU) announced the final results of a smallpox vaccine…
On Jul. 11, 2003, the U.S. Food and Drug Administration (FDA) published a final rule in the Federal…
On Jul. 10, 2003, the University Fertility Consultants at Oregon Health & Science University (OHSU) announced they had…
On Jul. 8, 2003, the U.S. Centers for Disease Control and Prevention (CDC) responded to U.S. outbreak of…
On Jul. 2, 2003, Invitrogen bought Molecular Probes for $325 million in cash. The company became part of…
In Jul. 2003, HB 3613 was passed in the Oregon State Legislature and enacted a mandate for the…
In July 2003, University of Saskatchewan researchers announced they had discovered “follicular waves” in the human menstrual cycle….
On Jun. 24, 2003, results of the Prostate Cancer Prevention Trial (PCPT), testing the effectiveness of finasteride to…
On Jun. 20, 2003, NanoString Technologies was incorporated in Seattle as a spin-off from the Institute for Systems…
On Jun. 20, 2003, Genentech drug Xolair (omalizumab) was approved by the U. S. Food and Drug Administration…
On Jun. 17, 2003, the first nasally administered influenza vaccine (FluMist by MedImmune) was licensed. This live influenza…
On Jun. 5, 2003, data from the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial gave fresh insight…
On May 30, 2003, the Attorney General of California consented to the sale of the assets of the…